Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The following table summarizes the stock-based compensation expense from stock option, employee stock purchase programs and restricted Common Stock awards and warrants for the three and nine months ended September 30, 2018 and 2017:

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
($ in thousands)	2018		2017		2018		2017
Employee Awards	$	1,012	$	1,104	$	3,075	$	3,528
Executive awards of Fortress Companies’ stock		446		546		1,408		1,642
Non-employee awards		24		24		70		60
Fortress Companies:
Avenue		371		246		1,043		269
Checkpoint		1,128		910		2,336		4,271
Mustang		922		834		3,888		1,231
Caelum		152		427		92		427
Other		51		93		141		308
National		929		129		1,605		312
Total stock-based compensation	$	5,035	$	4,313	$	13,658	$	12,048

Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding And Exercisable

The following table summarizes Fortress stock option activities excluding activity related to Fortress Companies:

	Number of Shares		Weighted average exercise price		Total weighted average intrinsic value		Weighted average remaining contractual life (years)
Options vested and expected to vest at December 31, 2017		1,110,501	$	3.78	$	1,351,080		3.95
Exercised		-		-		-		-
Options vested and expected to vest at September 30, 2018		1,110,501	$	3.78	$	87,132		3.21
Options vested and exercisable		1,085,501	$	3.75	$	87,132		3.18

Nonvested Restricted Stock Shares Activity

The following table summarizes Fortress restricted stock awards and restricted stock

unit awards

activities, excluding activities related to Fortress Companies:

	Number of Shares			Weighted average grant price
Unvested balance at December 31, 2017		11,874,034		$	2.63
Restricted stock granted		1,392,856			3.99
Restricted stock vested		(213,333	)		2.76
Restricted stock units granted		430,000			4.03
Restricted stock units forfeited		(426,978	)		4.05
Restricted stock units vested		(516,732	)		3.56
Unvested balance at September 30, 2018		12,539,847		$	2.74

Schedule of Warrant Activities

The following table summarizes Fortress warrant activities, excluding activities related to Fortress Companies:

	Number of Shares			Weighted average exercise price		Total weighted average intrinsic value		Weighted average remaining contractual life (years)
Outstanding as of December 31, 2017		2,774,189		$	3.30	$	2,204,530		4.47
Forfeited		(20,000	)		5.72		-		-
Outstanding as of September 30, 2018		2,754,189		$	3.28	$	13,800		3.75
Exercisable as of September 30, 2018		849,189		$	3.92	$	13,800		3.39

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details